Latest Products & Licence Changes

New drug - Toctino

Basilea has launched Toctino (alitretinoin) for the treatment of severe chronic hand eczema (CHE) in... Read more

New drug - Vimpat

UCB Pharma has launched Vimpat (lacosamide) for adjunctive therapy in the treatment of partial-onset... Read more

New drug - Firazyr

Firazyr (icatibant acetate) is indicated for the symptomatic treatment of acute attacks of hereditar... Read more

Safe use of fentanyl patches

The MHRA has issued best practice advice on the use of fentanyl patches after receiving reports of l... Read more

Licence extension for Apidra

The licence for Apidra (insulin glulisine) has been extended. Read more

Gardasil efficacy data

The summary of product characteristics (SPC) for Gardasil (human papillomavirus [HPV] types 6, 11, 1... Read more

Cymbalta for generalised anxiety disorder

The licence for Cymbalta (duloxetine) has been extended to include use in the treatment of generalis... Read more

Novopen 3 upgraded

NovoNordisk has updated the NovoPen 3 insulin injection pen to NovoPen 4. Read more

Humalog Kwikpens launched

Eli Lilly has launched KwikPen prefilled insulin pens in the Humalog insulin range. Read more

Probiotic approved for prescription

Ferring has launched VSL#3, an ACBS-approved probiotic indicated for the maintenance of remission of... Read more